Extended NO analysis in a healthy subgroup of a random sample from a Swedish population

Clinical Physiology and Functional Imaging

Volumn 29, Issue 1, 2009, Pages 18-23

  Högman, Marieann ^a   Lafih, Jaroslava ^a   Meriläinen, Pekka ^b   Bröms, Kristina ^a   Malinovschi, Andrei ^a   Janson, Christer ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b AALTO UNIVERSITY   (Finland)

Author keywords

Adults; Exhaled nitric oxide; Extended nitric oxide analysis; Flow rate; Gender; Health; Humans

Indexed keywords

IMMUNOGLOBULIN E; NITRIC OXIDE;

ADULT; AGE DISTRIBUTION; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EXHALATION; EXPIRATORY FLOW RATE; FEMALE; FORCED EXPIRATORY VOLUME; GAS ANALYSIS; HUMAN; HUMAN EXPERIMENT; LUNG ALVEOLUS WALL; LUNG DIFFUSION CAPACITY; MALE; NON INVASIVE MEASUREMENT; NORMAL HUMAN; NORMAL VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SWEDEN;

ADULT; AGE DISTRIBUTION; AGE FACTORS; ALGORITHMS; BODY HEIGHT; BREATH TESTS; EXHALATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NITRIC OXIDE; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; REFERENCE VALUES; SEX DISTRIBUTION; SEX FACTORS; SWEDEN;

EID: 58149305665     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2008.00831.x     Document Type: Article

References (32)

1. Standardized lung function testing report working party. Bull Eur Physiopathol Respir (1983); 19: 1-95.
2. The European Community Respiratory Health Survey II. Eur Respir J (2002); 20: 1071-1079.
3. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med (2005); 171: 912-930.
4. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J (2005); 26: 52-59.
5. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest (2007a); 131: 1353-1362.
6. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers. Chest (2007b); 132: 581-588.
7. George SC, Högman M, Permutt S, Silkoff PE. Modeling pulmonary nitric oxide exchange. J Appl Physiol (2004); 96: 831-839.
8. Grasemann H, Storm van's GK, Buscher R, Drazen JM, Ratjen F. Effects of sex and of gene variants in constitutive nitric oxide synthases on exhaled nitric oxide. Am J Respir Crit Care Med (2003); 167: 1113-1116.
9. Högman M, Meriläinen P. Extended NO analysis in asthma. J Breath Res (2007); 1: 024001.
10. Högman M, Strömberg S, Schedin U, Frostell C, Hedenstierna G, Gustafsson LE. Nitric oxide from the human respiratory tract efficiently quantified by standardized single breath measurements. Acta Physiol Scand (1997); 159: 345-346.
11. Högman M, Drca N, Ehrstedt C, Meriläinen P. Exhaled nitric oxide partitioned into alveolar, lower airways and nasal contributions. Respir Med (2000); 94: 985-991.
12. Högman M, Holmkvist T, Wegener T, Emtner M, Andersson M, Hedenström H, Meriläinen P. Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir Med (2002); 96: 24-30.
13. Lehtimäki L, Kankaanranta H, Saarelainen S, Hahtola P, Jarvenpaa R, Koivula T, Turjanmaa V, Moilanen E. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med (2001); 163: 1557-1561.
14. Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur Respir J (2002); 20: 841-845.
15. Maestrelli P, Ferrazzoni S, Visentin A, Marian E, Dal BD, Accordino R, Fabbri LM. Measurement of exhaled nitric oxide in healthy adults. Sarcoidosis Vasc Diffuse Lung Dis (2007); 24: 65-69.
16. Malinovschi A, Janson C, Holmkvist T, Norback D, Merilainen P, Hogman M. IgE sensitisation in relation to flow-independent nitric oxide exchange parameters. Respir Res (2006a); 7: 92.
17. Malinovschi A, Janson C, Holmkvist T, Norback D, Merilainen P, Hogman M. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J (2006b); 28: 339-345.
18. Olin AC, Rosengren A, Thelle DS, Lissner L, Bake B, Toren K. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest (2006); 130: 1319-1325.
19. Olin AC, Bake B, Toren K. Fraction of exhaled nitric oxide at 50 ml/s: reference values for adult lifelong never-smokers. Chest (2007); 131: 1852-1856.
20. Pedroletti C, Hogman M, Merilainen P, Nordvall LS, Hedlin G, Alving K. Nitric oxide airway diffusing capacity and mucosal concentration in asthmatic schoolchildren. Pediatr Res (2003); 54: 496-501.
21. Pietropaoli AP, Perillo IB, Torres A, Perkins PT, Frasier LM, Utell MJ, Frampton MW, Hyde RW. Simultaneous measurements of nitric oxide production by conductiong and alveolar airways of humans. J Appl Physiol (1999); 87: 1532-1542.
22. Roy K, Borrill ZL, Starkey C, Hazel AL, Morris J, Vestbo J, Singh D. Use of different exhaled nitric oxide multiple flow rate models in COPD. Eur Respir J (2007); 29: 651-659.
23. Shin HW, Rose-Gottron CM, Perez F, Cooper DM, Wilson AF, George SC. Flow-independent nitric oxide exchange parameters in healthy adults. J Appl Physiol (2001); 91: 2173-2181.
24. Shin HW, Rose-Gottron CM, Sufi RS, Perez F, Cooper DM, Wilson AF, George SC. Flow-independent nitric oxide exchange parameters in cystic fibrosis. Am J Respir Crit Care Med (2002); 165: 349-357.
25. Shin HW, Rose-Gottron CM, Cooper DM, Newcomb RL, George SC. Airway diffusing capacity of nitric oxide and steroid therapy in asthma. J Appl Physiol (2004); 96: 65-75.
26. Silkoff PE, McClean PA, Slutsky AS, Furlott HG, Hoffstein E, Wakita S, Chapman KR, Szalai JP, Zamel N. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med (1997); 155: 260-267.
27. Silkoff PE, Sylvester JT, Zamel N, Permutt S. Airway nitric oxide diffusion in asthma role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med (2000); 161: 1218-1228.
28. Stam H, Versprille A, Bogaard JM. The components of the carbon monoxide diffusing capacity in man dependent on alveolar volume. Bull Eur Physiopathol Respir (1983); 19: 17-22.
29. Stam H, Hrachovina V, Stijnen T, Versprille A. Diffusing capacity dependent on lung volume and age in normal subjects. J Appl Physiol (1994); 76: 2356-2363.
30. Taylor R, Mandhane P, Greene JM, Hancox RJ, Fisell S, McLachlan CR, Williamson AJ, Cowan JO, Smith AD, Sears MR. Factors affecting exhaled nitric oxide measurements: The effect of sex. Respir Res (2007); 8: 82.
31. Tsang KW, Ip SK, Leung R, Tipoe GL, Chan SL, Shum IH, Ip MS, Yan C, Fung PC, Chan-Yeung M, Lam W. Exhaled nitric oxide: The effects of age, gender and body size. Lung (2001); 179: 83-91.
32. Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol (1998); 85: 653-666.